221 |
A study on Stock floatation and Employee Stock Ownership Plan-an example for Chunghwa Telecom CompanyLo, Yi-chun 17 June 2005 (has links)
Abstract
There are lots of disadvantages such as the complicated of legal, the inefficiency of decision and the lack of performance. So the government had established ¡§The Privatization Promoting Group for the Executive Yuan of the Republic of China¡¨ in July 1989. The chairman of Council for economic planning and development was the convener. It had made a series of the privatization of stated-owned policy and planned the privatization of stated-owner¡¦s schedule according to different character.
Recently stock releasing had already failed. The government, the administration and the employee was dissatisfied with the process of stock releasing. So our study mentioned the design of financial imagination. This design was that led into employee stock ownership plan in the success of the privatization of state-owned and included stock ownership of stock floatation. Both of the close-ended periods were extended to the infinite period. At last our study took an example for Chunghwa Telecom Company and evaluated this design if whether can be executed.
My study found that this design could make the employee gain the director number of 1.3 to 2.6. It would enhance efficiently the director number and stabilize the employee ownership. My study expected that it had lots of advantages as follow:
(1) Benefit for the privatization of stated-owned
(2) Protecting the terms of the employee¡¦s equity
(3) Making the employee ownership system
(4) Solving the dispute between labor and capital
(5) Rational for the stated-wealth¡¦s evaluation
(6) Strengthening the corporate governance
|
222 |
Hormonal correlates of coloration and sexual change in the hermaphroditic grouper, Epinephelus adscensionisKline, Richard Joseph, 1970- 11 February 2011 (has links)
Hermaphroditism, associated with territoriality and dominance behavior, is common in the marine environment. Male sex-specific coloration patterns and behavior are particularly evident in species where males are territorial and guard harems of females such as wrasses and groupers. Protogynous hermaphrodites that change sex from female to male are good models to study sexual behavior and related changes in the brain due to their abilities to reorganize their sexual phenotype as adults. Two hormones produced in the brain and implicated in the process of sex-specific behavior and reproductive development are arginine vasotocin (AVT) and gonadotropin releasing hormone (GnRH). While a wealth of data exists regarding these hormone systems separately, little is known about linkage between these two systems. Especially there is no data tracking these two systems together in any protogynous fish. This study was conducted to test the hypothesis that coordinated interactions between AVT and GnRH facilitate the process of behavioral and gonadal sex change in the rock hind Epinephelus adscensionis. Four topics were addressed to investigate the relationship between behavior and reproduction: i) rock hind sex change, sexual characteristics and conditions causing sex change to occur in captivity were detailed as a basis for examining the AVT system and GnRH during this process, ii) the distribution of a vasotocin V1a type receptor identified in rock hind brain was examined for the first time in a fish species using a custom designed antibody then the receptor protein was co-localized with GnRH producing cells within the brain to confirm that a pathway exists for AVT action on GnRH, iii) levels of AVT, AVT receptors, and GnRH messenger RNA (mRNA) were compared between male and female rock hind phenotypes, and iv) female rock hind at early stages of sex change were compared for brain mRNA expression of AVT, AVT receptors, and GnRH to determine the order of hormonal change during the process of sexual inversion in this species. This study provides a better understanding of the relationship between sex-specific behavior and reproductive development via AVT and GnRH systems that are conserved in all vertebrates. / text
|
223 |
Direct Steroidal Regulation and Inhibitory Mode of Action of Gonadotropin-inhibitory Hormone (GnIH or RFRP-3) in Immortalized Hypothalamic Cell ModelsGojska, Nicole 18 June 2014 (has links)
Fertility is dependent on the precisely orchestrated communication of an array of effectors within the reproductive axis, all of which impinge on gonadotropin-releasing hormone (GnRH) neurons. A novel reproductive inhibitor was identified in avian species and growing evidence suggests that the functional mammalian homologue, RFamide-related peptide-3 (RFRP-3 or GnIH) can inhibit GnRH neuronal activity and gonadotropin release. To date, the regulation and effects of RFRP-3 at the hypothalamic level are poorly understood. We established an Rfrp-expressing neuronal cell model to investigate the mechanisms of transcriptional regulation of the genes for RFRP and the RFRP receptor, GPR147 by dexamethasone and estradiol. We show that the RFRP system is a direct target for stress-associated transcriptional regulation. Further, employing a novel GnRH-secreting cell line, we report that GnRH neurons express Gpr147 and RFRP-3 represses the transcription of GnRH. These data further our understanding of the level and regulatory effects at which RFRP-3 modulates reproduction.
|
224 |
Direct Steroidal Regulation and Inhibitory Mode of Action of Gonadotropin-inhibitory Hormone (GnIH or RFRP-3) in Immortalized Hypothalamic Cell ModelsGojska, Nicole 18 June 2014 (has links)
Fertility is dependent on the precisely orchestrated communication of an array of effectors within the reproductive axis, all of which impinge on gonadotropin-releasing hormone (GnRH) neurons. A novel reproductive inhibitor was identified in avian species and growing evidence suggests that the functional mammalian homologue, RFamide-related peptide-3 (RFRP-3 or GnIH) can inhibit GnRH neuronal activity and gonadotropin release. To date, the regulation and effects of RFRP-3 at the hypothalamic level are poorly understood. We established an Rfrp-expressing neuronal cell model to investigate the mechanisms of transcriptional regulation of the genes for RFRP and the RFRP receptor, GPR147 by dexamethasone and estradiol. We show that the RFRP system is a direct target for stress-associated transcriptional regulation. Further, employing a novel GnRH-secreting cell line, we report that GnRH neurons express Gpr147 and RFRP-3 represses the transcription of GnRH. These data further our understanding of the level and regulatory effects at which RFRP-3 modulates reproduction.
|
225 |
The Biological and Behavioural Effects of Electroconvulsive Stimulus in Rodents: Investigation and Translational Implications of a Genetic Animal Model of DepressionKyeremanteng, Catherine 15 February 2012 (has links)
Electroconvulsive therapy (ECT) is one of the oldest and most effective treatments for depression; however, its biological underpinnings are poorly understood. Brain-derived neurotrophic factor (BDNF) and the hypothalamic-pituitary-adrenal (HPA) axis are two chemical messenger systems implicated in the antidepressant action and cognitive side effects of ECT. The Wistar-Kyoto (WKY) strain is a genetic model of depression that shows biological, cognitive, behavioural, and treatment-response abnormalities, making it potentially a useful model in which to investigate the underpinnings of the action of electroconvulsive stimulus (ECS: the amimal model of ECT). In addition, the WKY presents a potentially useful model for translational research on depression. The WKY strain is particularly valuable for the measurement of serum BDNF protein, for which the association with antidepressant treatments is much less clear (mostly stemming from investigations in humans) than that between brain BDNF and antidepressant treatments in rodent studies.
The three studies presented add insight into the biological and behavioural effects of ECS. The first study (chapter 2) found no evidence of increased (R)-[11C]rolipram binding (an indirect marker of cyclic-adenosine monophosphate, cAMP) in the brain, despite significant increases of brain BDNF protein expression after repeated ECS. The second study (chapter 3) demonstrated the validity of the WKY strain in the investigation of ECS. Relative to Wistar controls, WKY showed similar antidepressant and cognitive effects (despite some abnormal behavioural responses), immediate but not sustained increases in brain BDNF protein, and a novel finding of increased extra-hypothalamic CRF after 5 daily ECS. The final study (chapter 4) demonstrated baseline strain differences in serum (WKY < Wistar) but not brain BDNF and, in both strains, no change in serum BDNF despite significant changes in brain BDNF after repeated ECS treatment. Preliminary results from a human pilot study investigating similar measures in a small group of people receiving ECT for depression are also presented.
The results of this body of work advance our understanding of the activation and role of brain and serum measures of BDNF and the HPA axis in ECS/ECT, and raise important issues in the translation of research from basic science to the human condition of depression.
|
226 |
Design, synthesis, and evaluation of radiolabeled bombesin conjugates for the diagnosis of breast cancerRetzloff, Lauren Brooke, Smith, Charles J. January 2009 (has links)
The entire dissertation/thesis text is included in the research.pdf file; the official abstract appears in the short.pdf file (which also appears in the research.pdf); a non-technical general description, or public abstract, appears in the public.pdf file. Title from PDF of title page (University of Missouri--Columbia, viewed on March 25, 2010). Vita. Thesis advisor: Charles J. Smith. "December 2009" Includes bibliographical references.
|
227 |
Efeito do antagonista de receptor do peptídeo liberador de gastrina na resposta inflamatória por lesão de reperfusão pulmonar em ratosFreitas, Vera Lorentz de Oliveira January 2014 (has links)
A lesão de isquemia e reperfusão pulmonar (LIRI) é a principal causa de disfunção precoce do enxerto após o transplante pulmonar. Diferentes substâncias têm sido utilizadas na tentativa de proteger o pulmão na fase inicial pós-transplante e melhorar o desempenho do enxerto com pouco resultado tanto a curto quanto em longo prazo. O peptídeo liberador gastrina (GRP) está envolvido na indução de respostas imunes inatas adaptativas por induzir a quimiotaxia de mastócitos, migração de macrófagos e proliferação de células T e fibroblastos. Este agente foi capaz de proteger o dano tecidual em outros modelos experimentais de inflamação, incluindo sepsis pós-isquemia e perfuração de ceco, artrite e colite induzidos por drogas. O efeito protetor foi atribuído ao bloqueio na liberação de citocinas pró-inflamatórias, como da interleucina -1 beta (IL-1G) e TNF- alfa (TNF-H), e inibição de migração de mononucleares. Nesta tese o efeito protetor do antagonista do receptor de peptídeo liberador de gastrina (GRPR), o RC-3095 (RC) endovenosamente administrado antes e depois da reperfusão foi estudado em modelo animal de LIRI. Vinte ratos Wistar foram randomizados em quatro grupos: (SHAM), Isquemia-reperfusão (IR), administração de RC Pré-IR (RC-Pré) e RC Pós-IR (RC-Pós). Após a reperfusão, os animais foram observados por 120 minutos. Foi realizada a análise histológica, com verificação de escala de lesão pulmonar, e imunohistoquímica para Caspase clivada - 9 e oxido nítrico sintetase endotelial (eNOS). Expressão de IL-1G e TNF-H foram quantificadas por Enzime-Linked Immunosorbent Assay (ELISA). Uma redução significativa na pressão arterial média foi observada nos grupos IR e RC - Pré quando comparado com seus valores antes da reperfusão (p < 0.001). No final do experimento o grupo RC-Pós apresentou uma redução significativa na pressão arterial de oxigênio em relação ao início (p=0.005). Observou-se maior expressão de Caspase - 9 clivada no grupo RC-Pós (p>0.013), quando comparado aos demais grupos. Não houve diferença significativa na captação da eNOS entre os grupos (p=0.206). Os grupos RC - Pré e Pós mostraram discreta redução, não atingindo significância estatística, da IL-1G (p=0.159) e TNF- H (p= 0.260), quando comparado com o grupo IR. Não houve diferença estatística entre as médias dos escores histológicos entre os diferentes grupos. e SHAM. Notavelmente, quando administrado após reperfusão parece potencializar dano celular estimulando a apoptose. Concluindo, a utilização do antagonista do peptídeo liberador de gastrina, RC-3095, não produziu efeito protetor significativo na resposta inflamatória em pulmões de ratos. Estudos adicionais devem ser implementados para confirmar estes achados. / Lung ischemia reperfusion injury (LIRI) is the main cause of early graft dysfunction and death after lung transplantation. Several methods and substances have been used as an attempt to protect the lung during the early phase after transplantation and improve graft performance at short and long term with limited results. The selective gastrin-releasing peptide receptor (GRPR) antagonist RC-3095 (RC) was shown to protect from damage in various models of inflammation, including sepsis due to cecal ischemia and perforation, drug-induced arthritis and colitis, probably due to the inhibition in the release of proinflammatory cytokines, such as interleukin-1-beta and TNFalpha, as well as interference with mononuclear migration. In this thesis, the protective effect of the selective gastrin-releasing peptide receptor (GRPR) antagonist RC-3095, administrated intravenous before and after reperfusion was studied in an animal model of LIRI. A total of 20 Wistar rats were randomized in four groups: (SHAM), Ischemia-reperfusion (IR), RC Pre-IR (RCPre) and the RC Post-IR (RC-Post) .The IR groups were submitted to a model of ischemia/reperfusion by clamping of the left pulmonary hilum for 45 minutes followed by reperfusion for 120 minutes. We recorded the hemodynamic parameters, blood gas analysis and histology. We analyzed Cleaved Caspase- 9 and endothelial nitric oxide synthase (eNOS) by immunohistochemistry. Expression of IL-1G and TNF-H was evaluated by Enzyme-Linked Immunosorbent Assay (ELISA). We observed that the final mean arterial pressure significantly decreased in IR and RC Pre-IR compared to their values before reperfusion (p < 0.001).The RC-Post group showed significant decrease of partial pressure of arterial oxygen at the end of the observation compared to baseline (p=0.005). Caspase-9 activity was significantly higher in the RC-Post- IR as compared to the other groups (p < 0.013). No significant differences were observed of eNOS activity among the groups. The groups RC Pre-IR e RC Post-IR did not show a significant decrease of IL-1G (p=0.159) and TNF-H (p= 0.260), as compared to IR. The histological score showed no significant differences among the groups. Notably, its use after reperfusion seems to potentiate cell damage, stimulating apoptosis In conclusion, RC3095, a selective GRPR antagonist failed to demonstrate a significant protective effect in our LIRI model in male Wistar rats. Further studies to address this question are warranted.
|
228 |
Efeitos do antagonista dos receptores Gastrin-Releasing Peptide (GRP) sobre peso, alimentação, parâmetros metabólicos, bioquímicos e composição corporal de ratos wistarCruz, Luciane Beitler da January 2014 (has links)
Introdução e objetivo: Gastrin-releasing peptide (GRP) está envolvido em diversas funções cerebrais e gastrointestinais, incluindo secreção pancreática, liberação de hormônios peptídeos gastrointestinais e redução da ingestão alimentar. O objetivo deste estudo é testar os efeitos da injeção intraperitoneal do antagonista do receptor GRP sobre o peso, ingestão alimentar, parâmetros metabólicos e bioquímicos e composição corporal. Métodos: Foram utilizados 35 ratos Wistar adultos jovens, submetidos a uma perda ponderal mínima de 7%, divididos em quatro grupos: Grupo Controle (G0) que recebeu injeção de solução salina; Grupo 1 (G1) que recebeu 0,1 mg/kg de RC-3095; Grupo 2 (G2) que recebeu 0,3 mg/kg de RC-3095 e Grupo 3 (G3) que recebeu 1,0 mg/kg de RC-3095 durante 14 dias. Resultados: A variação da média diária de ingestão alimentar foi estatisticamente diferente entre os grupos (F: 3,139; df: 3; P = 0,039) e o G2, que recebeu a dose intermediária de 0,3 mg/kg de RC-3095, mostrou uma ingestão alimentar maior do que o G0 (P = 0,041). Houve um aumento similar do peso, de aproximadamente 22% (F: 0,572; df: 3; P = 0,638), assim como uma média de peso similar dos animais (F: 1,145; df: 9,685; P = 0,338) entre os grupos durante o período do estudo. Porém, a média de peso do G2 foi mais alta do que a média de peso dos animais do G0 (P = 0,042). Ao final do estudo, nenhuma diferença foi observada entre os grupos no total de massa magra ou de massa gorda da carcaça, fígado e pele dos animais. Comparando os níveis séricos de albumina, amilase, glicose, colesterol total, HDL-colesterol e interleucina-6 do Dia 1 (D1) para o Dia 14 (D14), não houve diferença estatisticamente relevante entre os grupos. Entretanto, o nível médio de triglicerídeos no G2 mostrou um aumento maior quando comparado ao G0 (P = 0,038). Conclusões: Neste estudo, a injeção da dose intermediária do antagonista do receptor GRP, o RC-3095 (0,3 mg/kg/dia), em ratos Wistar adultos jovens saudáveis submetidos a perda ponderal, interferiu na ingestão alimentar e no peso médio. Nenhum efeito sobre o ganho de peso, composição corporal ou parâmetros metabólicos e bioquímicos foi observado, exceto um aumento maior do nível sérico de triglicerídeos. Estes resultados demonstram alguns dos efeitos fisiológicos do GRP sobre a ingestão alimentar e peso, ampliando possibilidades de futuros estudos sobre fome, saciedade e metabolismo de macronutrientes ou em animais submetidos a uma condição de estresse maior, como o câncer. / Introduction and Objective: Gastrin-releasing peptide (GRP) is involved in several brain and gastrointestinal functions, including pancreatic secretion, gastrointestinal peptide hormone release, and reduction of food intake. We tested the effects of an intraperitoneal injection of the GRP receptor (GRPR) antagonist RC-3095 on weight, food intake, biochemical metabolic parameters, and body composition. Methods: Thirty-five young adult male Wistar rats, submitted to a minimal weight loss of 7%, were divided into four groups: the control group (G0) received saline; Group 1 (G1) received 0.1 mg/kg RC-3095; Group 2 (G2) received 0.3 mg/kg RC-3095; and Group 3 (G3) received 1.0 mg/kg RC-3095 for 14 days. Results: The mean daily variation of food intake was statistically different between the groups (F: 3.139; df: 3; P = 0.039); and G2, which received the intermediate dose of 0.3 mg/kg RC-3095, showed a greater food intake than G0 (P = 0.041). There was a similar increase in weight, approximately 22% (F: 0.572; df: 3; P = 0.638), as well as a similar mean animal weight (F: 1.145; df: 9.685; P = 0.338) between the groups during the study period. However, the mean weight of G2 animals was more than the mean weight of G0 animals (P = 0.042). At the end of the study, no difference was observed between the groups in terms of the total lean mass or fat mass from the rat carcass, liver, and skin. Comparing the serum levels of albumin, amylase, glucose, total cholesterol, high-density lipoprotein (HDL) cholesterol, and interleukin (IL)-6 from day 1 (D1) to D14, there were no statistically relevant differences between the groups. However, the mean triglyceride level in G2 compared to G0 showed a greater increase (P = 0.038). Conclusion: In this study, the injection of an intermediate dose of GRPR antagonist RC- 3095 (0.3 mg/kg/day) into healthy young adult Wistar rats submitted to weight loss affected food intake and the mean weight. No effects on weight gain, body composition, or biochemical metabolic parameters were observed, except for a great increase in the serum triglyceride levels. These results demonstrate some physiological effects of GRP on food intake and weight, expanding the possibilities of future studies on hunger/satiety and macronutrient metabolism as well as highly stressful conditions like cancer.
|
229 |
Reprodução de papagaio-verdadeiro (Amazona aestiva) em cativeiro: perfil anual de esteróides sexuais e ensaio de estímulo hormonal exógenoChristofoletti, Mauricio Durante [UNESP] 03 February 2014 (has links) (PDF)
Made available in DSpace on 2015-04-09T12:28:09Z (GMT). No. of bitstreams: 0
Previous issue date: 2014-02-03Bitstream added on 2015-04-09T12:48:07Z : No. of bitstreams: 1
000815988.pdf: 670904 bytes, checksum: df849f5b7af31dd25a1aabd5ab80b4cd (MD5) / O Brasil é o país com a maior diversidade de psitacídeos do mundo, abrigando 72 espécies reconhecidas, com 16 espécies presentes no “Livro Vermelho da Fauna Brasileira Ameaçada de Extinção”. O papagaio-verdadeiro (Amazona aestiva) se destaca por sua popularidade como animal de estimação, sendo coletado na natureza em grande número para atender ao mercado ilegal de animais silvestres. Sua reprodução em cativeiro pode se tornar uma ferramenta para a conservação das populações na natureza, porém isso exige uma criação baseada em conhecimentos científicos e técnicas avançadas de reprodução. Esta tese teve como objetivos apresentar o perfil anual endócrino dos esteroides sexuais do Amazona aestiva e realizar um ensaio de estímulo hormonal através da aplicação de análogo de GnRH de liberação lenta na espécie. Utilizamos 10 casais e 4 machos adultos da espécie Amazona aestiva mantidos em viveiros suspensos, pertencentes ao Criadouro da Brisa, situado Jaboticabal/SP. As excretas foram coletadas ao menos uma vez por semana entre junho de 2011 e julho de 2012 para entendimento dos processos endócrinos que regem a reprodução da espécie e entre agosto de 2012 e dezembro de 2012 no ensaio de estímulo hormonal. O monitoramento da atividade gonadal foi feita de forma não invasiva por mensuração de metabólitos de andrógenos nas excretas dos machos e de progestágenos nas excretas de fêmeas. Foram coletadas amostras frescas de excretas, sempre no período entre 14h as 17h, e mantidas congeladas até o processamento. As amostras foram secas em estufa a 57oC, trituradas e os hormônios extraídos utilizando metanol a 80%. A dosagem hormonal foi realizada no Laboratório de Endocrinologia do NUPECCE (Núcleo de Pesquisa e Conservação de Cervídeos) utilizando ensaio imunoenzimático com o anticorpo para andrógenos e progestágenos. No ensaio de estimulo hormonal exógeno com analago de GnRH foi aplicado ... / Brazil is the country with the greatest diversity of parrots in the world , with to 72 recognized species , with 16 species in the Red List of Endangered Brazilian Wild Animals . The blue-fronted amazon parrot ( Amazona aestiva ) stands out for its popularity as a pet , being collected from the wild in large numbers to attend the illegal market for wildlife. His captive breeding can become a tool for the conservation of populations in nature , but this requires a creation based on scientific knowledge and advanced breeding techniques . This thesis aimed to present the annual endocrine profile of sex steroids of Amazona aestiva and a test of hormonal stimulation by applying GnRH analogue of the slow release. It was used 10 couples and 4 adult males of Amazona aestiva kept in suspended cages, properties of the commercial breeder “Criadouro da Brisa”, located in Jaboticabal / SP. The droppings were collected at least once a week between June 2011 and July 2012 for the understanding of endocrine processes of the reproduction in this specie and between August 2012 and December 2012 for testing hormonal stimulation . The monitoring of gonadal activity was noninvasively by measuring androgen metabolites in droppings of males and females of droppings progestogens. Fresh droppings samples were collected , always in between 14h to 17h , and kept frozen until processing . The samples were dried at 57oC, crushed and hormones were extracted using 80% methanol . The hormone dosage was performed at the Laboratory of Endocrinology, NUPECCE ( Center for Research and Conservation of Deer ) using enzyme immunoassay with antibody to androgens and progestins . In exogenous hormone stimulation test with GnRH was applied analago buserelin slow release in 5 couples and 5 couples were used to control the following excreta collection , processing and hormonal dosage previously described . The results of the annual listing of androgens in males ...
|
230 |
Papel dos mecanismos mediados pelo fator de liberação de corticotrofina e pelo complexo receptor N-Metil-D-Aspartato-Óxido Nítrico nas reações associadas a estímulos aversivos /Miguel, Tarciso Tadeu. January 2010 (has links)
Resumo: Os confrontos dos animais com situações que induzem medo e ansiedade resultam em uma série de respostas comportamentais defensivas (ex. luta, fuga, imobilidade, vocalização, etc.), ativação neurovegetativa (ex. taquicardia, hipertensão, defecação, etc.), antinocicepção, além de influenciar o comportamento agressivo e aumentar a vulnerabilidade à dependência e recaída ao uso de drogas. Com base no potencial efeito ansiogênico dos neurotransmissores glutamato (via ativação do complexo receptor NMDA-óxido nítrico) e fator liberador de corticotrofina (via receptores CRF1 e CRF2), este estudo investigou o papel desses mediadores, através de injeções sistêmicas, na matéria cinzenta periaquedutal (MCP) ou no núcleo dorsal da rafe (NDR), nas respostas apontadas acima. Os seguintes modelos foram utilizados: labirinto em cruz elevado (LCE, ansiedade), injeção de formalina a 2,5% (nocicepção), conflito intruso-residente (agressão) e estresse de derrota social (dependência à cocaína). Os resultados indicaram: a) o efeito ansiogênico do agonista de receptores NMDA (N-metil-D-aspartato; NMDA) na MCP foi antagonizado pela inibição da enzima de síntese de NO, b) os efeitos ansiogênico e antinociceptivo do CRF na MCP foram via ativação de receptores CRF1 (mas não CRF2) e independentes de NO, c) os efeitos aversivo e antinociceptivo do NO (via administração de um doador de NO) na MCP mostraram-se sensíveis ao bloqueio de receptores CRF1, d) a ativação de receptores CRF2 intra-NDR reduziu o comportamento agressivo induzido pelo conflito intruso-residente, e) o tratamento sistêmico com antagonista CRF1 bloqueou a sensibilização comportamental à cocaína e atenuou o aumento do consumo da mesma induzidos pelo estresse da derrota social / Abstract: Animal confrontation against fear/anxiety-induced situations results in a repertory of behavioral defensive responses (e.g., fight, flight, immobility, vocalization), neurovegetative activation (e.g., tachycardia, hypertension, defecation), antinociception, as well as affects aggressive behavior and increases animals vulnerability to addiction and relapse to drug take. Based on the potential anxiogenic effect elicited by glutamate (via activation of NMDA-nitric oxide receptor complex) and corticotropin releasing factor (via CRF1 and CRF2 receptors), this study investigated the effect of systemic, intra-periaqueductal gray (PAG) or intradorsal raphe nucleus (DRN) injections of these mediators on the above described responses. The following animal models were used: elevated plus maze (EPM, anxiety test), formalin 2.5% injection (nociceptive test), resident-intruder conflict (aggression test) and social defeat stress (to induce cocaine addiction). Results indicated that: a) the anxiogenic effect elicited by intra-PAG injection of glutamate NMDA (N-methyl-D-aspartate; NMDA) receptor agonist was antagonized by prior local infusion an NO synthase inhibitor, b) the anxiogenic and antinociceptive effects elicited by intra-PAG CRF were mediated by CRF1 (but not CRF2) receptor activation and did not depend on NO synthesis, c) the aversive and antinociceptive effects of NO production (induced by intra-PAG injection of a NO donor) were sensitive to CRF1 blockade, d) activation of the CRF2 receptor within the DRN attenuated aggressive behavior elicited by resident-intruder conflict, e) systemic treatment with CRF1 receptor antagonist inhibited cocaine behavioral sensitization and social-defeat stress-induced cocaine consumption / Orientador: Ricardo Luiz Nunes de Souza / Coorientador: Klaus A. Miczek / Banca: Cleopatra da Silva Planeta / Banca: Fabrício Moreira / Banca: Hélio Zangrossi Júnior / Banca: Marcus Lira Brandão / Doutor
|
Page generated in 0.0697 seconds